Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. I. Clinical and laboratory findings.
D000293:Adolescent; D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D001002:Anuria / Q000209:etiology; D001437:Bacteriuria / Q000209:etiology; D001772:Blood Cell Count; D001794:Blood Pressure; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D004487:Edema / Q000209:etiology; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control / Q000652:urine; D006417:Hematuria / Q000209:etiology; D006454:Hemoglobins; D006801:Humans; D007198:Indians, North American; D007223:Infant; D007677:Kidney Function Tests; D008297:Male; D008910:Minnesota; D010406:Penicillins / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D011711:Pyoderma / Q000150:complications* / Q000453:epidemiology; D012737:Sex Factors; D013290:Streptococcal Infections / Q000453:epidemiology*; D013291:Streptococcus / Q000302:isolation & purification; D013997:Time Factors
D000906:Antibodies; D006454:Hemoglobins; D010406:Penicillins; D003404:Creatinine